ResearchMoz

Worldwide Tablet TFT-LCD Panel Industry, 1Q 2014

Market Intelligence & Consulting Institute
Published Date » 2014-04-14
No. Of Pages » 10
 This research report presents shipment volume forecast and recent quarter review of the worldwide TFT-LCD panels used in tablets. The report includes tablet TFT-LCD panel shipment volume, shipment volume and share by panel size, as well as shipment breakdown by manufacturer's country of origin. The content of this report is based on primary data obtained through interviews with TFT-LCD panel makers. The report finds that shipment volume of the worldwide tablet TFT-LCD panels witnessed over 60% year-on-year growth and over 70% sequentially growth in the fourth quarter of 2014, reaching around 89.2 million units.  
   
 While 7.x" tablets still remained the mainstream in the fourth quarter of 2013, the worldwide shipment volume of TFT-LCD panels for 9.x" and...
Table of Contents

Worldwide Tablet TFT-LCD Panel Shipment Volume, 4Q 2011 - 2Q 2014
Worldwide Tablet TFT-LCD Panel Shipment Volume by Size, 4Q 2011 - 4Q 2013
Worldwide Tablet TFT-LCD Panel Shipment Share by Size, 4Q 2011 - 4Q 2013
Worldwide Tablet TFT-LCD Panel Shipment Volume by Manufacturer's Country of Origin, 4Q 2011 - 4Q 2013
Worldwide Tablet TFT-LCD Panel Shipment Share by Manufacturer's Country of Origin, 4Q 2011 - 4Q 2013
Intelligence Insight
Research Scope & Definitions

List of Tables


List of Figures

Upcoming Reports:

Biologics Market - G7 Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
With an increase in the number of clinical trials in the past 5 years, the market for biologics is expected to witness a high growth during the coming years. Monoclonal antibodies, vaccines and therapeutic proteins will contribute significantly to the growth in the biologics market. The global biologics market is estimated to reach $176.4 billion by the end of 2012 and expected to grow at an annual compound growth rate of more than 9.5%. In the U.S. the market will witness significant growth, due to a resolution passed by the U.S. lawmakers in 2010; There is increasing...
Antifungal Drugs: Technologies And The Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018
By - Transparency Market Research
Fungal infections occur due to unhygienic, damp, and unclean environment. They are caused by microscopic organisms that can invade the epithelial tissue. Most dermal infections are the tinea group of infections and are commonly observed in people. They affect nails, hair, scalp, and the skin in various areas of the body. Systemic fungal infections are caused by the ingestion or inhalation of spores and cause fungal pneumonia and opportunistic fungus causes diseases such as candidaisis, meningitis, mucormycosis and some others. There is a very broad base of fungal diseases in humans...
Oil Storage Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Global oil storage market is composed of many small independent owners and will experience growth in the coming future. This can be attributed to the demand for oil storage which is rising at the major global supply hubs because of increased trade between countries and is expected to continue with the leading terminals worldwide as the major beneficiaries.  The global market for oil storage has seen a rapid growth due to increasing oil prices over the last few years.  The rise in demand for oil in some of the countries in South East Asia is likely to propel...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Blackstone Invests $800 Million in Asian Oil-Based Energy Company
Jul 31, 2014  
Blackstone Energy Partners announced to invest $800 million in an Asian based energy company that is led by former industry executives.  Blackstone is popularly considered a part of the world’s largest administrator of alternatives to financial stocks and bonds. New York-based managing director, Angelo Acconcia of Blackstone Energy Partners said in an interview that Tamarind...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...